on Comparison alone with PYC, RHT should be around $439 million Market cap,
second Company I would like to compare :
4DX - lungs Imaging, losing 8 million per quarter, Market cap is - $263 Million dollars
RHT - has Lungs smart AI based technology do the same job and with better accuracy, RHT will eventually apply for FDA approval , Still making money on quarterly basis without funding through recurring capital raise like other companies do in the market.
After comparing two projects with PYC and 4DX ,New valuation of RHT should be $702 Million Market cap
I will come back with my comparison of Third company tomorrow,
It's not a investment advice, DYOR, I just believe in the company and the management team and would like to share my analysis.
Ann: US FDA Clearance for LiverSmart, page-25
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.15M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 68513 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 660000 | 1 |
View Market Depth
| Last trade - 10.58am 27/09/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable